| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Recommendations for chamber quantification.
|
Eur J Echocardiogr
|
2006
|
11.39
|
|
2
|
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.
|
Circulation
|
2008
|
3.30
|
|
3
|
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial.
|
J Am Coll Cardiol
|
2011
|
2.84
|
|
4
|
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial.
|
Circulation
|
2011
|
2.62
|
|
5
|
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
|
Circulation
|
2008
|
2.59
|
|
6
|
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
|
Circulation
|
2011
|
2.56
|
|
7
|
Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).
|
Circulation
|
2011
|
2.08
|
|
8
|
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
|
J Am Coll Cardiol
|
2006
|
1.71
|
|
9
|
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure.
|
Eur Heart J
|
2015
|
1.68
|
|
10
|
Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
|
Arterioscler Thromb Vasc Biol
|
2007
|
1.20
|
|
11
|
Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.
|
Biol Blood Marrow Transplant
|
2004
|
1.14
|
|
12
|
Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia.
|
J Clin Oncol
|
2009
|
1.09
|
|
13
|
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.
|
Eur J Heart Fail
|
2013
|
1.04
|
|
14
|
Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2005
|
1.03
|
|
15
|
Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF.
|
Eur J Heart Fail
|
2014
|
0.99
|
|
16
|
Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT).
|
J Card Fail
|
2010
|
0.90
|
|
17
|
Comparative numerical study on left ventricular fluid dynamics after dilated cardiomyopathy.
|
J Biomech
|
2013
|
0.90
|
|
18
|
New developments in allotransplant immunology.
|
Hematology Am Soc Hematol Educ Program
|
2003
|
0.88
|
|
19
|
Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES).
|
Eur J Heart Fail
|
2014
|
0.87
|
|
20
|
The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease.
|
Clin Trials
|
2011
|
0.86
|
|
21
|
Clonal dominance of chronic myelogenous leukemia is associated with diminished sensitivity to the antiproliferative effects of neutrophil elastase.
|
Blood
|
2003
|
0.85
|
|
22
|
Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.
|
Eur Heart J
|
2013
|
0.85
|
|
23
|
Functional strain-line pattern in the human left ventricle.
|
Phys Rev Lett
|
2012
|
0.83
|
|
24
|
Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
|
Eur Heart J
|
2004
|
0.83
|
|
25
|
Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
|
Eur J Heart Fail
|
2015
|
0.81
|
|
26
|
Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis.
|
Eur J Heart Fail
|
2010
|
0.81
|
|
27
|
Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function.
|
Am J Cardiol
|
2008
|
0.79
|
|
28
|
Left ventricular pacing threshold and outcome in MADIT-CRT.
|
J Cardiovasc Electrophysiol
|
2014
|
0.78
|
|
29
|
EXCEED: Exforge-intensive control of hypertension to evaluate efficacy in diastolic dysfunction: study rationale, design, and participant characteristics.
|
Ther Adv Cardiovasc Dis
|
2009
|
0.78
|
|
30
|
Left atrial volume and the benefit of cardiac resynchronization therapy in the MADIT-CRT trial.
|
Circ Heart Fail
|
2013
|
0.77
|
|
31
|
Central aortic pulsatile hemodynamics in obese premenopausal women.
|
J Am Soc Hypertens
|
2010
|
0.77
|
|
32
|
Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction.
|
J Am Coll Cardiol
|
2006
|
0.76
|
|
33
|
Prostaglandin inhibition and cardiovascular risk: maybe timing really is everything.
|
Cancer Prev Res (Phila)
|
2009
|
0.76
|
|
34
|
Effect of radiofrequency catheter ablation of ventricular tachycardia on left ventricular function in patients with prior myocardial infarction.
|
J Interv Card Electrophysiol
|
2002
|
0.76
|
|
35
|
Response to Letter Regarding Article, “Cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk In the Community Study”.
|
Circ Heart Fail
|
2015
|
0.75
|
|
36
|
Effectiveness of cardiac resynchronization therapy by the frequency of revascularization procedures in ischemic cardiomyopathy patients.
|
Cardiol J
|
2016
|
0.75
|
|
37
|
CardioPulse: drinking moderate amounts of alcohol is linked to reduced risk of heart failure.
|
Eur Heart J
|
2015
|
0.75
|
|
38
|
Transthoracic Echocardiography to Assess Aortic Regurgitation after TAVR: A Comparison with Periprocedural Transesophageal Echocardiography.
|
Cardiology
|
2016
|
0.75
|